Literature DB >> 1808607

Solubilization and wetting effects of bile salts on the dissolution of steroids.

V Bakatselou1, R C Oppenheim, J B Dressman.   

Abstract

The ability of sodium taurocholate to increase the initial dissolution rate of five steroids was studied in terms of effects on solubility, wetting, and diffusion coefficient. For all compounds, wetting effects predominated over solubilization effects at bile salt concentrations representative of the fasted state. For hydrocortisone, triamcinolone, betamethasone, and dexamethasone, this trend also continued at the higher bile salt concentrations typical of the fed state. Bile salts solubilized these compounds by a factor of two or less, and diffusivity changes were negligible at bile salt concentrations up to 30 mM. For the more lipophilic danazol, the wetting effects were small and of importance only at premicellar levels of bile salt. At higher concentrations, the increase in solubility was the predominant factor. Incorporation into micelles appeared to decrease the diffusivity slightly, but this was important only at bile salts concentrations of 15 mM or higher. In conclusion, it appears that even within a series of structurally related compounds the mechanism by which bile salts mediate increases in dissolution rate can differ considerably.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1808607     DOI: 10.1023/a:1015877929381

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  25 in total

1.  Physiologic surface-active agents and drug absorption. IV. Effect of pre-micellar concentrations of surfactant on dissolution rate.

Authors:  H Weintraub; M Gibaldi
Journal:  J Pharm Sci       Date:  1969-11       Impact factor: 3.534

2.  Micelle formation and testosterone solubilization by sodium glycocholate.

Authors:  L Martis; N A Hall; A L Thakkar
Journal:  J Pharm Sci       Date:  1972-11       Impact factor: 3.534

3.  In vitro dissolution from several experimental capsule formulations.

Authors:  J C Samyn; W Y Jung
Journal:  J Pharm Sci       Date:  1970-02       Impact factor: 3.534

4.  [Bile salts and lipids in aqueous intraluminal phase during the digestion of a standard meal in normal man (author's transl)].

Authors:  M Rautureau; A Bisalli; J C Rambaud
Journal:  Gastroenterol Clin Biol       Date:  1981-04

5.  The role of surfactants in the release of very slightly soluble drugs from tablets.

Authors:  H Schott; L C Kwan; S Feldman
Journal:  J Pharm Sci       Date:  1982-09       Impact factor: 3.534

6.  Solubilizing properties of bile salt solutions. II. Effect of inorganic electrolyte, lipids, and a mixed bile salt system on solubilization of glutethimide, griseofulvin, and hexestrol.

Authors:  T R Bates; M Gibaldi; J L Kanig
Journal:  J Pharm Sci       Date:  1966-09       Impact factor: 3.534

7.  Establishment of sink conditions in dissolution rate determinations. Theoretical considerations and application to nondisintegrating dosage forms.

Authors:  M Gibaldi; S Feldman
Journal:  J Pharm Sci       Date:  1967-10       Impact factor: 3.534

8.  On the concentration of bile acids in the human intestine during absorption. Bile acids and sterioids 74.

Authors:  J SJOVALL
Journal:  Acta Physiol Scand       Date:  1959-08-31

9.  Bile acid output and the interdigestive migrating motor complex in normals and in cholecystectomy patients.

Authors:  T L Peeters; G Vantrappen; J Janssens
Journal:  Gastroenterology       Date:  1980-10       Impact factor: 22.682

10.  Duodenal bile acid concentrations in fat malabsorption syndromes.

Authors:  H Westergaard
Journal:  Scand J Gastroenterol       Date:  1977       Impact factor: 2.423

View more
  31 in total

1.  Dissolution of hydrocortisone in human and simulated intestinal fluids.

Authors:  B L Pedersen; H Brøndsted; H Lennernäs; F N Christensen; A Müllertz; H G Kristensen
Journal:  Pharm Res       Date:  2000-02       Impact factor: 4.200

2.  Dissolution testing as a prognostic tool for oral drug absorption: dissolution behavior of glibenclamide.

Authors:  R Löbenberg; J Krämer; V P Shah; G L Amidon; J B Dressman
Journal:  Pharm Res       Date:  2000-04       Impact factor: 4.200

3.  A comparison of the solubility of danazol in human and simulated gastrointestinal fluids.

Authors:  B L Pedersen; A Müllertz; H Brøndsted; H G Kristensen
Journal:  Pharm Res       Date:  2000-07       Impact factor: 4.200

4.  Improvement of dissolution rates of poorly water soluble APIs using novel spray freezing into liquid technology.

Authors:  Jiahui Hu; True L Rogers; Judith Brown; Tim Young; Keith P Johnston; Robert O Williams
Journal:  Pharm Res       Date:  2002-09       Impact factor: 4.200

Review 5.  The use of biorelevant dissolution media to forecast the in vivo performance of a drug.

Authors:  Sandra Klein
Journal:  AAPS J       Date:  2010-05-11       Impact factor: 4.009

Review 6.  Biowaivers for oral immediate-release products: implications of linear pharmacokinetics.

Authors:  Fried Faassen; Herman Vromans
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

7.  Increasing the proportional content of surfactant (Cremophor EL) relative to lipid in self-emulsifying lipid-based formulations of danazol reduces oral bioavailability in beagle dogs.

Authors:  Jean F Cuiné; William N Charman; Colin W Pouton; Glenn A Edwards; Christopher J H Porter
Journal:  Pharm Res       Date:  2007-02-15       Impact factor: 4.200

8.  Postprandial changes in solubilizing capacity of human intestinal fluids for BCS class II drugs.

Authors:  Sarah Clarysse; Dimitrios Psachoulias; Joachim Brouwers; Jan Tack; Pieter Annaert; Guus Duchateau; Christos Reppas; Patrick Augustijns
Journal:  Pharm Res       Date:  2009-03-07       Impact factor: 4.200

9.  Gastric juice as a dissolution medium: surface tension and pH.

Authors:  M Efentakis; J B Dressman
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1998 Apr-Jun       Impact factor: 2.441

10.  Solubilization of drugs by physiological mixtures of bile salts.

Authors:  Timothy Scott Wiedmann; Wei Liang; Lamya Kamel
Journal:  Pharm Res       Date:  2002-08       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.